System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3985-3998
Author(s):
Juan Sebastian Yakisich
Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6584-6643
Author(s):
Roger Gilabert-Oriol, Alexander Weng, Benedicta von Mallinckrodt, Matthias F. Melzig, Hendrik Fuchs and Mayank Thakur
NCRNA Combined Therapy as Future Treatment Option for Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6565-6574
Author(s):
Cornelia Braicu, Cristina Catana, George A. Calin and Ioana Berindan-Neagoe
Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6452-6465
Author(s):
Orit Uziel and Meir Lahav
Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
557-566
Author(s):
Meng-Hang Yang, Yuan-Sheng Zang, Hai Huang, Kun Chen, Bing Li, Guang-Yuan Sun and Xue-Wei Zhao
Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3029-3041
Author(s):
Hongping Xia and Kam M. Hui
The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy
Journal:
Current Drug Targets
Volume:
15
Page:
674-680
Author(s):
Ping Sui, Hongxin Cao, Long Meng, Pingping Hu, Honghai Ma and Jiajun Du
Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2346-2356
Author(s):
Joshua K. Ko and Kathy K. Auyeung
Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2899-2911
Author(s):
Liangkun You, Changyu Liu, Hexiao Tang, Yongde Liao and Shengling Fu
Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
559-577
Author(s):
Leo Veenman, Moshe Gavish and Wilfried Kugler